Characteristic | SCH non-intervention Group (n = 103) | SCH treatment Group (n = 319) | Control group (n = 9598) | P value |
---|---|---|---|---|
Age (years) | 31.84(3.83) | 30(28–33) | 30(28–33) | 0.014 |
BMI (kg/m2) | 22.70(3.77) | 21.56(19.61–24.01) | 21.48(19.83–23.44) | 0.115 |
TSH (mIU/L) | 4.56(4.22–5.22) | 4.75(4.33–5.59) | 1.34(0.96–1.79) | < 0.001 |
FT4 (pmol/L) | 14.73(1.43) | 14.76(1.47) | 15.92(14.77–16.91) | < 0.001 |
GA at delivery (wks) | 39 (38–40) | 38 (38–40) | 39 (38–40) | 0.695 |
Neonatal weight (g) | 3349.08(399.47) | 3307.07(483.43) | 3350 (3085–3620) | 0.249 |
History of adverse pregnancy outcomes, n (%) | 3 (2.91) | 3 (0.94) | 159(1.66) | 0.294 |
History of hypertension, n (%) | 1 (0.97) | 3(0.94) | 40(0.42) | 0.532 |
History of diabetes, n (%) | 0 | 0 | 31 (0.32) | |
Cesarean section rate, n (%) | 41 (39.81) | 117(36.68) | 3374(35.15) | 0.154 |